Improving translational studies: lessons from rare neuromuscular diseases
Animal models play a key role in the development of novel treatments for human disease. This is particularly true for rare diseases - defined as disorders that affect less than 1 in 2000 people in the human population - for which, very often, there are no effective methods of treatment. Pharmaceutic...
Saved in:
Main Author: | Dominic Wells (Author) |
---|---|
Format: | Book |
Published: |
The Company of Biologists,
2015-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Improving translatability of preclinical studies for neuromuscular disorders: lessons from the TREAT-NMD Advisory Committee for Therapeutics (TACT)
by: Raffaella Willmann, et al.
Published: (2020) -
Translational medicine in neuromuscular disorders: from academia to industry
by: Belinda S. Cowling, et al.
Published: (2020) -
Improving Recognition of Treatable Rare Neuromuscular Disorders in Primary Care: A Pilot Feasibility Study
by: Federica S. Ricci, et al.
Published: (2022) -
The predictive value of models of neuromuscular disorders to potentiate clinical translation
by: Maaike van Putten
Published: (2022) -
Translating multiscale research in rare disease
by: Kirsty M. Hooper, et al.
Published: (2024)